[Clinico-therapeutic evaluation of a new drug combination with hepatotrophic effect].
D000225:Adenine / Q000627:therapeutic use*; D000328:Adult; D002648:Child; D004338:Drug Combinations; D005492:Folic Acid / Q000627:therapeutic use*; D006506:Hepatitis A / Q000150:complications; D006801:Humans; D006879:Hydroxocobalamin / Q000627:therapeutic use*; D007288:Inosine / Q000627:therapeutic use; D008107:Liver Diseases / Q000188:drug therapy*; D008715:Methionine / Q000627:therapeutic use*; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D009705:Nucleosides / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D004338:Drug Combinations; D009705:Nucleosides; D009536:Niacinamide; D007288:Inosine; D005492:Folic Acid; D008715:Methionine; D000225:Adenine; D014805:Vitamin B 12; D006879:Hydroxocobalamin; D012256:Riboflavin
Valutazione clinico terapeutica di un nuovo farmaco di associazione ad azione epatotrofica.